|
Volumn 43, Issue 26, 2000, Pages 5037-5043
|
Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
N 3 BENZYLIMIDAZOQUINAZOLINONE SULFONAMIDE DERIVATIVE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHODIESTERASE V;
PHOSPHODIESTERASE V INHIBITOR;
PYRAZOLOPYRIMIDINE DERIVATIVE;
SILDENAFIL;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CORPUS CAVERNOSUM;
DOG;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
NONHUMAN;
RABBIT;
STRUCTURE ACTIVITY RELATION;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
ANIMALS;
CATTLE;
DOGS;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
MALE;
MUSCLE, SMOOTH;
MUSCLES;
PENIS;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
QUINAZOLINES;
RABBITS;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0034727872
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm000336j Document Type: Article |
Times cited : (35)
|
References (17)
|